Latest Ceo Transition News

BHP has reported robust copper and iron ore production for the nine months to March 2026, with key projects progressing and a leadership change set for July. Operational resilience and disciplined capital moves underpin its outlook.

Buru Energy has enhanced the Rafael Gas Project’s mid-case value by over 45% through new engineering insights, while securing A$5.3 million to advance development. The company delayed appraisal drilling to 2027 to optimise funding and project design, and navigates a leadership change with CEO Thomas Nador stepping down.

Noronex completed maiden drilling programs at key uranium and copper projects while bolstering its cash position through strategic asset sales. The company also formalised a 51% stake in its Etango North uranium project and navigates a CEO transition.

Canyon Resources advances its Minim Martap Bauxite Project with trial mining underway and first ore shipment set for Q3 2026, while navigating executive departures and solidifying funding.

Select Harvests Limited has announced the resignation of CEO and Managing Director David Surveyor, who led the company through a significant operational transformation and financial recovery from a loss in FY23 to a $31.8 million profit in FY25. Surveyor will remain for a six-month transition period while the company searches for his successor.

Resouro Strategic Metals has appointed Simon Stilwell as Independent Non-Executive Chairman, with Christopher Eager stepping into the CEO role, marking a significant leadership reshuffle as the company advances its rare earths and titanium projects in Brazil.

Cluey Ltd announces significant leadership changes including the retirement of a long-serving director and a CEO stepping down, while affirming continuity in its strategic direction.

Wide Open Agriculture has appointed Craig Swan as its new CEO, signaling a strategic push to commercialise its lupin protein technology and expand its footprint in Asia.

Opthea Limited reports a striking turnaround with a $339.9 million profit for H1 2026, driven by a strategic refocus on developing OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women. The company plans a rebrand and ASX reinstatement as it charts a new course in rare respiratory health.

Steadfast Group announces the planned retirement of co-founder and CEO Robert Kelly AM, initiating a structured leadership transition with a new CEO expected by August 2026.

Tinybeans Group announces a leadership reshuffle with Tracy Cho as Interim CEO and Rebecca White joining the Board, sharpening its focus on expanding in the lucrative U.S. family market.

Mayne Pharma has announced a planned leadership transition with CFO Aaron Gray stepping up as CEO, succeeding Shawn Patrick O’Brien who will remain as an advisor during the handover.